Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

Impact of 3,4-Dihydroxy-6-18F-Fluoro-l-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective

Franziska Walter, Timothy Cloughesy, Martin A. Walter, Albert Lai, Phioanh Nghiemphu, Naveed Wagle, Barbara Fueger, Nagichettiar Satyamurthy, Michael E. Phelps and Johannes Czernin
Journal of Nuclear Medicine March 2012, 53 (3) 393-398; DOI: https://doi.org/10.2967/jnumed.111.095711
Franziska Walter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy Cloughesy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin A. Walter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Lai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phioanh Nghiemphu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naveed Wagle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Fueger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nagichettiar Satyamurthy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E. Phelps
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Czernin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 53 no. 3 393-398
DOI 
https://doi.org/10.2967/jnumed.111.095711
PubMed 
22323780

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication July 14, 2011
  • Accepted for publication November 3, 2011
  • Published online March 5, 2012.

Article Versions

  • previous version (February 9, 2012 - 11:15).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2012 by the Society of Nuclear Medicine, Inc.

Author Information

  1. Franziska Walter1,2,
  2. Timothy Cloughesy3,
  3. Martin A. Walter1,2,4,
  4. Albert Lai3,
  5. Phioanh Nghiemphu3,
  6. Naveed Wagle3,
  7. Barbara Fueger1,2,
  8. Nagichettiar Satyamurthy1,
  9. Michael E. Phelps1 and
  10. Johannes Czernin1,2
  1. 1Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California
  2. 2Ahmanson Translational Imaging Division, UCLA, Los Angeles, California
  3. 3Department of Neurology, UCLA, Los Angeles, California; and
  4. 4Department of Nuclear Medicine, University of Bern, Bern, Switzerland
  1. For correspondence or reprints contact: Johannes Czernin, David Geffen School of Medicine at UCLA, Ahmanson Biological Imaging Division, 10833 Le Conte Avenue, Room AR-243 CHS, Los Angeles, CA 90095-1782. E-mail: jczernin{at}mednet.ucla.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 40 Citations
  • 44 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
    Nathalie L. Albert, Michael Weller, Bogdana Suchorska, Norbert Galldiks, Riccardo Soffietti, Michelle M. Kim, Christian la Fougère, Whitney Pope, Ian Law, Javier Arbizu, Marc C. Chamberlain, Michael Vogelbaum, Ben M. Ellingson, Joerg C. Tonn
    Neuro-Oncology 2016 18 9
  • The role of LAT1 in 18F-DOPA uptake in malignant gliomas
    Ryan S. Youland, Gaspar J. Kitange, Timothy E. Peterson, Deanna H. Pafundi, Judi A. Ramiscal, Jenny L. Pokorny, Caterina Giannini, Nadia N. Laack, Ian F. Parney, Val J. Lowe, Debra H. Brinkmann, Jann N. Sarkaria
    Journal of Neuro-Oncology 2013 111 1
  • Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy
    Johannes Schwarzenberg, Johannes Czernin, Timothy F. Cloughesy, Benjamin M. Ellingson, Whitney B. Pope, Tristan Grogan, David Elashoff, Cheri Geist, Daniel H.S. Silverman, Michael E. Phelps, Wei Chen
    Clinical Cancer Research 2014 20 13
  • Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients
    K. Herrmann, J. Czernin, T. Cloughesy, A. Lai, K. L. Pomykala, M. R. Benz, A. K. Buck, M. E. Phelps, W. Chen
    Neuro-Oncology 2014 16 4
  • Non-invasive metabolic imaging of brain tumours in the era of precision medicine
    Michelle M. Kim, Abhijit Parolia, Mark P. Dunphy, Sriram Venneti
    Nature Reviews Clinical Oncology 2016 13 12
  • Comparison of the Amino Acid Tracers18F-FET and18F-DOPA in High-Grade Glioma Patients
    Constantin Lapa, Thomas Linsenmann, Camelia Maria Monoranu, Samuel Samnick, Andreas K. Buck, Christina Bluemel, Johannes Czernin, Almuth F. Kessler, Gyoergy A. Homola, Ralf-Ingo Ernestus, Mario Löhr, Ken Herrmann
    Journal of Nuclear Medicine 2014 55 10
  • PET/CT in Oncology: Current Status and Perspectives
    Johannes Czernin, Martin Allen-Auerbach, David Nathanson, Ken Herrmann
    Current Radiology Reports 2013 1 3
  • Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors
    Aixia Sun, Xiang Liu, Ganghua Tang
    Frontiers in Chemistry 2018 5
  • Increasing feasibility and utility of 18 F-FDOPA PET for the management of glioma
    Christopher Bell, Nicholas Dowson, Simon Puttick, Yaniv Gal, Paul Thomas, Mike Fay, Jye Smith, Stephen Rose
    Nuclear Medicine and Biology 2015 42 10
  • 18F-FLT    and 18F-FDOPA PET kinetics in recurrent brain tumors
    Mirwais Wardak, Christiaan Schiepers, Timothy F. Cloughesy, Magnus Dahlbom, Michael E. Phelps, Sung-Cheng Huang
    European Journal of Nuclear Medicine and Molecular Imaging 2014 41 6

Article usage

Article usage: March 2012 to April 2025

AbstractFullPdf
Feb 2012255030
Mar 2012193648208
Apr 20124172049
May 20123161325
Jun 2012185622
Jul 20121701112
Aug 201210949
Sep 20121433328
Oct 20121194624
Nov 20121463621
Dec 20121172315
Jan 20131033120
Feb 20131196720
Mar 2013731626
Apr 2013641818
May 2013753915
Jun 201339418
Jul 201335919
Aug 201336109
Sep 2013361518
Oct 2013201714
Nov 2013401312
Dec 20132957
Jan 201412128
Feb 2014261117
Mar 2014321311
Apr 201420813
May 2014271215
Jun 20142485
Jul 201436917
Aug 2014957
Sep 201442158
Oct 201425155
Nov 20143078
Dec 201423138
Jan 20151072
Feb 201538219
Mar 20154367
Apr 20152938
May 20153221
Jun 201519106
Jul 20151169
Aug 20151424
Sep 20151566
Oct 20151542
Nov 201525114
Dec 201552152
Jan 20163495
Feb 201646167
Mar 201618212
Apr 20162377
May 201636518
Jun 201619811
Jul 20162749
Aug 20161127
Sep 2016932
Oct 201614123
Nov 2016121112
Dec 201614711
Jan 20171011
Feb 20171171
Mar 20171196
Apr 2017943
May 20171443
Jun 2017553
Jul 20171771
Aug 20173643
Sep 20171963
Oct 20171896
Nov 20178114
Dec 201761212
Jan 20181948
Feb 20181334
Mar 2018948
Apr 2018953
May 2018694
Jun 20181123
Jul 2018612
Aug 2018855
Sep 2018622
Oct 2018431
Nov 2018720
Dec 2018921
Jan 2019743
Feb 2019831
Mar 20191949
Apr 2019838
May 201910511
Jun 2019613
Jul 2019938
Aug 2019722
Sep 20197137
Oct 20191426
Nov 2019444
Dec 20191343
Jan 2020833
Feb 202010624
Mar 20201275
Apr 20201053
May 2020957
Jun 20204134
Jul 2020712
Aug 2020633
Sep 20201442
Oct 2020814
Nov 202015311
Dec 20201738
Jan 2021678
Feb 202181715
Mar 20211256
Apr 20213127
May 202142010
Jun 20217184
Jul 202141314
Aug 2021597
Sep 20212135
Oct 202131517
Nov 20212912
Dec 20213234
Jan 20226165
Feb 202251911
Mar 20223186
Apr 20224208
May 202231111
Jun 20223185
Jul 20220166
Aug 20222123
Sep 202202113
Oct 2022183
Nov 20221104
Dec 20223102
Jan 202363514
Feb 202310123
Mar 202312612
Apr 202322210
May 2023585
Jun 20234134
Jul 20232511
Aug 2023155
Sep 20235156
Oct 20232102
Nov 202331610
Dec 20235284
Jan 20242355
Feb 2024071
Mar 20242433
Apr 202436817
May 20242224
Jun 20245205
Jul 202443413
Aug 202482513
Sep 202433916
Oct 20244246
Nov 20244283
Dec 20243201
Jan 202512111
Feb 202521044
Mar 20255399
Apr 202583827
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 53 (3)
Journal of Nuclear Medicine
Vol. 53, Issue 3
March 1, 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of 3,4-Dihydroxy-6-18F-Fluoro-l-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Impact of 3,4-Dihydroxy-6-18F-Fluoro-l-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective
Franziska Walter, Timothy Cloughesy, Martin A. Walter, Albert Lai, Phioanh Nghiemphu, Naveed Wagle, Barbara Fueger, Nagichettiar Satyamurthy, Michael E. Phelps, Johannes Czernin
Journal of Nuclear Medicine Mar 2012, 53 (3) 393-398; DOI: 10.2967/jnumed.111.095711

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Impact of 3,4-Dihydroxy-6-18F-Fluoro-l-Phenylalanine PET/CT on Managing Patients with Brain Tumors: The Referring Physician's Perspective
Franziska Walter, Timothy Cloughesy, Martin A. Walter, Albert Lai, Phioanh Nghiemphu, Naveed Wagle, Barbara Fueger, Nagichettiar Satyamurthy, Michael E. Phelps, Johannes Czernin
Journal of Nuclear Medicine Mar 2012, 53 (3) 393-398; DOI: 10.2967/jnumed.111.095711
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE STATEMENT
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Evaluation of 11C-Methionine PET and Anatomic MRI Associations in Diffuse Intrinsic Pontine Glioma
  • The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma
  • Comparison of the Amino Acid Tracers 18F-FET and 18F-DOPA in High-Grade Glioma Patients
  • Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy
  • Google Scholar

More in this TOC Section

  • Feasibility of Ultra-Low-Activity 18F-FDG PET/CT Imaging Using a Long–Axial-Field-of-View PET/CT System
  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire